Fischer, Carina <br/><br/>
Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.  [electronic resource] 

 -  Molecular cancer  Jan 2015 
 - 4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-14-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cisplatin--pharmacology<br/>DNA Fragmentation--drug effects<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Epithelial Cells--drug effects<br/>Gene Expression<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Histone Deacetylases--genetics<br/>Histones--metabolism<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Hypoxia--metabolism<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Indoles--pharmacology<br/>Lung Neoplasms--genetics<br/>Panobinostat<br/>Spheroids, Cellular--drug effects<br/>Tumor Cells, Cultured